CATEGORIES

Press Release

LATEST

TRENDING

EDITORS CHOICE

Voluntary Recall: Two Lots of NP Thyroid® Tablets, Due to Sub Potency

Acella Pharmaceuticals, LLC is voluntarily recalling one lot of 15-mg and one lot of 120-mg NP Thyroid®, Thyroid Tablets, USP [levothyroxine (T4) and liothyronine (T3)] to the consumer level.

Product Recall: Amiodarone HCl Injection, USP and Tranexamic Acid Injection, USP

Mylan Initiates Voluntary Nationwide Recall of Four Lots of Amiodarone HCl Injection, USP and Tranexamic Acid Injection, USP Due to Carton Label Mix-Up

The Diversion of Drugs Within Healthcare Needs to be Addressed

The Protenus Drug Diversion Digest found that over half of diversion incidents took place in a hospital, medical center, or physician practice setting

Genome Editing and Cellular Therapies Show Promise for Treating Blood Disorders, Cancers

Three studies report promising results in the use of cutting-edge genome editing and cellular therapies for hard-to-treat blood disorders and cancers.